company background image
DRREDDY logo

Dr. Reddy's Laboratories NSEI:DRREDDY Stok Raporu

Son Fiyat

₹1.19k

Piyasa Değeri

₹993.4b

7D

-0.3%

1Y

3.0%

Güncellenmiş

28 Nov, 2024

Veri

Şirket Finansalları +

Dr. Reddy's Laboratories Limited

NSEI:DRREDDY Stok Raporu

Piyasa değeri: ₹993.4b

Dr. Reddy's Laboratories Limited Rakipler

Fiyat Geçmişi ve Performans

için tüm zamanların en yüksek seviyelerinin, değişikliklerin ve fiyat düşüşlerinin özeti Dr. Reddy's Laboratories
Tarihsel hisse senedi fiyatları
Güncel Hisse Fiyatı₹1,191.95
52 Haftanın En Yüksek Seviyesi₹1,421.49
52 Haftanın En Düşük Seviyesi₹1,074.00
Beta0.33
11 Aylık Değişim-6.49%
3 Aylık Değişim-15.24%
1 Yıllık Değişim2.96%
33 Yıllık Değişim27.82%
5 Yıllık Değişim107.54%
Halka arzdan bu yana değişim1,237.39%

Son Haberler & Güncellemeler

Are Dr. Reddy's Laboratories Limited (NSE:DRREDDY) Investors Paying Above The Intrinsic Value?

Nov 23
Are Dr. Reddy's Laboratories Limited (NSE:DRREDDY) Investors Paying Above The Intrinsic Value?

Dr. Reddy's Laboratories Limited Just Missed EPS By 12%: Here's What Analysts Think Will Happen Next

Nov 08
Dr. Reddy's Laboratories Limited Just Missed EPS By 12%: Here's What Analysts Think Will Happen Next

Insufficient Growth At Dr. Reddy's Laboratories Limited (NSE:DRREDDY) Hampers Share Price

Nov 01
Insufficient Growth At Dr. Reddy's Laboratories Limited (NSE:DRREDDY) Hampers Share Price

Recent updates

Are Dr. Reddy's Laboratories Limited (NSE:DRREDDY) Investors Paying Above The Intrinsic Value?

Nov 23
Are Dr. Reddy's Laboratories Limited (NSE:DRREDDY) Investors Paying Above The Intrinsic Value?

Dr. Reddy's Laboratories Limited Just Missed EPS By 12%: Here's What Analysts Think Will Happen Next

Nov 08
Dr. Reddy's Laboratories Limited Just Missed EPS By 12%: Here's What Analysts Think Will Happen Next

Insufficient Growth At Dr. Reddy's Laboratories Limited (NSE:DRREDDY) Hampers Share Price

Nov 01
Insufficient Growth At Dr. Reddy's Laboratories Limited (NSE:DRREDDY) Hampers Share Price

Is Dr. Reddy's Laboratories (NSE:DRREDDY) Using Too Much Debt?

Oct 14
Is Dr. Reddy's Laboratories (NSE:DRREDDY) Using Too Much Debt?

If EPS Growth Is Important To You, Dr. Reddy's Laboratories (NSE:DRREDDY) Presents An Opportunity

Aug 19
If EPS Growth Is Important To You, Dr. Reddy's Laboratories (NSE:DRREDDY) Presents An Opportunity

Dr. Reddy's Laboratories Limited (NSE:DRREDDY) Exceeded Expectations And The Analyst Consensus Has Been Reviewing Its Models

Aug 01
Dr. Reddy's Laboratories Limited (NSE:DRREDDY) Exceeded Expectations And The Analyst Consensus Has Been Reviewing Its Models

The Market Doesn't Like What It Sees From Dr. Reddy's Laboratories Limited's (NSE:DRREDDY) Earnings Yet

Jul 30
The Market Doesn't Like What It Sees From Dr. Reddy's Laboratories Limited's (NSE:DRREDDY) Earnings Yet

Dr. Reddy's Laboratories (NSE:DRREDDY) Seems To Use Debt Rather Sparingly

Jul 12
Dr. Reddy's Laboratories (NSE:DRREDDY) Seems To Use Debt Rather Sparingly

Dr. Reddy's Laboratories (NSE:DRREDDY) Will Pay A Dividend Of ₹40.00

Jun 23
Dr. Reddy's Laboratories (NSE:DRREDDY) Will Pay A Dividend Of ₹40.00

Additional Considerations Required While Assessing Dr. Reddy's Laboratories' (NSE:DRREDDY) Strong Earnings

Jun 20
Additional Considerations Required While Assessing Dr. Reddy's Laboratories' (NSE:DRREDDY) Strong Earnings

Dr. Reddy's Laboratories (NSE:DRREDDY) Is Paying Out A Dividend Of ₹40.00

May 26
Dr. Reddy's Laboratories (NSE:DRREDDY) Is Paying Out A Dividend Of ₹40.00

Dr. Reddy's Laboratories (NSE:DRREDDY) Will Pay A Dividend Of ₹40.00

May 10
Dr. Reddy's Laboratories (NSE:DRREDDY) Will Pay A Dividend Of ₹40.00

With EPS Growth And More, Dr. Reddy's Laboratories (NSE:DRREDDY) Makes An Interesting Case

May 06
With EPS Growth And More, Dr. Reddy's Laboratories (NSE:DRREDDY) Makes An Interesting Case

There Is A Reason Dr. Reddy's Laboratories Limited's (NSE:DRREDDY) Price Is Undemanding

Apr 18
There Is A Reason Dr. Reddy's Laboratories Limited's (NSE:DRREDDY) Price Is Undemanding

Earnings Beat: Dr. Reddy's Laboratories Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Feb 02
Earnings Beat: Dr. Reddy's Laboratories Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Should You Be Adding Dr. Reddy's Laboratories (NSE:DRREDDY) To Your Watchlist Today?

Jan 19
Should You Be Adding Dr. Reddy's Laboratories (NSE:DRREDDY) To Your Watchlist Today?

Why Investors Shouldn't Be Surprised By Dr. Reddy's Laboratories Limited's (NSE:DRREDDY) Low P/E

Jan 01
Why Investors Shouldn't Be Surprised By Dr. Reddy's Laboratories Limited's (NSE:DRREDDY) Low P/E

Dr. Reddy's Laboratories (NSE:DRREDDY) Has A Rock Solid Balance Sheet

Oct 21
Dr. Reddy's Laboratories (NSE:DRREDDY) Has A Rock Solid Balance Sheet

If EPS Growth Is Important To You, Dr. Reddy's Laboratories (NSE:DRREDDY) Presents An Opportunity

Oct 03
If EPS Growth Is Important To You, Dr. Reddy's Laboratories (NSE:DRREDDY) Presents An Opportunity

Dr. Reddy's Laboratories (NSE:DRREDDY) Could Easily Take On More Debt

Jul 14
Dr. Reddy's Laboratories (NSE:DRREDDY) Could Easily Take On More Debt

Dr. Reddy's Laboratories (NSE:DRREDDY) Is Increasing Its Dividend To ₹40.00

Jun 24
Dr. Reddy's Laboratories (NSE:DRREDDY) Is Increasing Its Dividend To ₹40.00

Dr. Reddy's Laboratories (NSE:DRREDDY) Is Paying Out A Larger Dividend Than Last Year

Jun 10
Dr. Reddy's Laboratories (NSE:DRREDDY) Is Paying Out A Larger Dividend Than Last Year

Dr. Reddy's Laboratories (NSE:DRREDDY) Is Increasing Its Dividend To ₹40.00

May 27
Dr. Reddy's Laboratories (NSE:DRREDDY) Is Increasing Its Dividend To ₹40.00

Dr. Reddy's Laboratories' (NSE:DRREDDY) Dividend Will Be Increased To ₹40.00

May 13
Dr. Reddy's Laboratories' (NSE:DRREDDY) Dividend Will Be Increased To ₹40.00

Is Dr. Reddy's Laboratories (NSE:DRREDDY) Using Too Much Debt?

Apr 11
Is Dr. Reddy's Laboratories (NSE:DRREDDY) Using Too Much Debt?

If EPS Growth Is Important To You, Dr. Reddy's Laboratories (NSE:DRREDDY) Presents An Opportunity

Mar 06
If EPS Growth Is Important To You, Dr. Reddy's Laboratories (NSE:DRREDDY) Presents An Opportunity

These 4 Measures Indicate That Dr. Reddy's Laboratories (NSE:DRREDDY) Is Using Debt Reasonably Well

Jan 10
These 4 Measures Indicate That Dr. Reddy's Laboratories (NSE:DRREDDY) Is Using Debt Reasonably Well

If EPS Growth Is Important To You, Dr. Reddy's Laboratories (NSE:DRREDDY) Presents An Opportunity

Dec 05
If EPS Growth Is Important To You, Dr. Reddy's Laboratories (NSE:DRREDDY) Presents An Opportunity

Hissedar Getirileri

DRREDDYIN PharmaceuticalsIN Pazar
7D-0.3%0.8%2.9%
1Y3.0%42.1%28.9%

Getiri vs. Endüstri: DRREDDY geçen yıl % 42.1 oranında getiri sağlayan Indian Pharmaceuticals sektörünün gerisinde kaldı.

Getiri vs Piyasa: DRREDDY geçen yıl % 28.9 oranında getiri sağlayan Indian Piyasasının altında performans gösterdi.

Fiyat Oynaklığı

Is DRREDDY's price volatile compared to industry and market?
DRREDDY volatility
DRREDDY Average Weekly Movement2.5%
Pharmaceuticals Industry Average Movement6.0%
Market Average Movement6.1%
10% most volatile stocks in IN Market9.0%
10% least volatile stocks in IN Market4.0%

İstikrarlı Hisse Senedi Fiyatı: DRREDDY son 3 ayda önemli bir fiyat oynaklığı yaşamadı.

Zaman İçindeki Volatilite: DRREDDY 'nin haftalık oynaklığı ( 2% ) son bir yıldır istikrarlı seyretti.

Şirket Hakkında

KurulduÇalışanlarCEOWeb sitesi
198427,048Erez Israeliwww.drreddys.com

Dr. Reddy's Laboratories Limited, iştirakleri ile birlikte dünya çapında entegre bir ilaç şirketi olarak faaliyet göstermektedir. Global Jenerik, Farmasötik Hizmetler ve Etkin Maddeler (PSAI) ve Diğer segmentleri aracılığıyla faaliyet göstermektedir. Şirketin Global Jenerik segmenti, bir marka adı altında veya markalı formülasyonlara terapötik eşdeğerliğe sahip jenerik bitmiş dozajlar olarak pazarlanan reçeteli ve reçetesiz bitmiş farmasötik ürünler üretmekte ve pazarlamakta ve ayrıca biyolojik ürünler işiyle uğraşmaktadır.

Dr. Reddy's Laboratories Limited Temel Bilgiler Özeti

Dr. Reddy's Laboratories'un kazançları ve gelirleri piyasa değeriyle nasıl karşılaştırılır?
DRREDDY temel i̇stati̇sti̇kler
Piyasa değeri₹993.43b
Kazançlar(TTM)₹53.33b
Gelir(TTM)₹299.87b

18.6x

F/K Oranı

3.3x

P/S Oranı

Kazanç ve Gelir

En son kazanç raporundan temel karlılık istatistikleri (TTM)
DRREDDY gelir tablosu (TTM)
Gelir₹299.87b
Gelir Maliyeti₹122.07b
Brüt Kâr₹177.80b
Diğer Giderler₹124.47b
Kazançlar₹53.33b

Son Raporlanan Kazançlar

Sep 30, 2024

Sonraki Kazanç Tarihi

n/a

Hisse başına kazanç (EPS)64.03
Brüt Marj59.29%
Net Kâr Marjı17.79%
Borç/Özkaynak Oranı14.2%

DRREDDY uzun vadede nasıl bir performans gösterdi?

Geçmiş performansı ve karşılaştırmayı görün

Temettüler

0.7%

Mevcut Temettü Verimi

12%

Ödeme Oranı